Should we use FEV1/FVC <0.70 or FEV1/FVC <LLN to identify subjects with a clinical history indicating COPD – Results from the population-based BOLD study in Salzburg, Austria Source: Annual Congress 2011 - COPD diagnosis Year: 2011
The prevalence of COPD in Annaba, Algeria: Results of the BOLD study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Can GLI reference values be used to analyse longitudinal data from elderly women in Germany? Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
Quality of spirometries to assess possible COPD in current smokers. Results from an ongoing study in general practice in Switzerland Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005
The prevalence of COPD in an African city: Results of the BOLD study, Ile-Ife, Nigeria Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
The recent multi-ethnic global lung initiative 2012 (GLI2012 ) reference values don’t reflect contemporary Mediterranean spirometry Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Spirometry in the 5000 subjects of the LifeGene pilot study in Sweden: Evaluating different reference equations, BMI and thorax measurements Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016
Do we need local controls for multi-centre trials? Lung function measurements in 3 UK centres Source: Annual Congress 2005 - New lung function techniques in paediatric pulmonology Year: 2005
Interpreting spirometry data from South Asian children using the GLI-2012 equations: The SLIC study Source: Annual Congress 2013 –Lung function and sleep studies in children: technical aspects and clinical applications Year: 2013
Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study Source: Annual Congress 2013 –Treatment of asthma Year: 2013
Applicability of the global lung initiative (GLI) spirometric reference values for northern Sweden Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study Source: Eur Respir J 2004; 24: Suppl. 48, 87s Year: 2004
Comparing COPD care in Malta, to other European hospitals: Results from the ERS COPD audit Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Use of spirometry in family practice in Canada; results of a nationwide survey Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Impact of frailty on interpretability of spirometry: The Rotterdam study Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008